Substituted aminobutyric derivatives as neprilysin inhibitors
申请人:Novartis AG
公开号:US08263629B2
公开(公告)日:2012-09-11
The present invention provides a compound of formula I′;
or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, X and n are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
申请人:Coppola Gary Mark
公开号:US20120252830A1
公开(公告)日:2012-10-04
The present invention provides a compound of formula I′;
or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
, R
3
, X and n are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS
申请人:COPPOLA Gary Mark
公开号:US20150174089A1
公开(公告)日:2015-06-25
The present invention provides a compound of formula I′;
or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
, R
3
, X and n are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.